findmyKOL

Jason Margolesky, MD

Basic profile

University of Miami

ORCIDNPI
RegionMiami, FL · SoutheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jason Margolesky is a Neurology physician affiliated with University of Miami. OpenAlex indexes 93 publications with 614 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
93publications

Distinct works indexed by OpenAlex, matched via ORCID.

614citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1611 NW 12th Ave
Central Building, Room 600-D
Miami, FL 331361005

Telephone

305-355-1122

Registry record last updated 3 Sept 2019.

View the NPPES registry record

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    73.9%
    Neuromuscular Blocker73.5%
    Onabotulinumtoxina100%
    Part B, office-administered12 patients
    gamma-Aminobutyric Acid-ergic Agonist0.2%
    Baclofen100%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    24.8%
    Aromatic Amino Acid Decarboxylation Inhibitor8.6%
    Carbidopa-Levodopa53%Rytary22%Carbidopa-Levodopa Er18%Carbidopa-Levodopa-Entacapone6%Crexont2%
    Part D<11 patients
    Influenza A M2 Protein Inhibitor2.3%
    Gocovri59%Amantadine41%
    Part D23 patients

    + 16 more classes in this area

  • Cardiovascular

    0.9%
    Beta blocker0.6%
    Propranolol Hcl Er73%Propranolol Hcl28%
    Part D<11 patients
    alpha-Adrenergic Agonist0.3%
    Midodrine Hcl100%
    Part D<11 patients
Where care is delivered (Part B)1.1% facility · 98.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”